Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway

被引:56
|
作者
Ding, Jieqiong [1 ,2 ]
Tang, Qiong [1 ,2 ]
Luo, Binhua [3 ]
Zhang, Lijun [1 ]
Lin, Li [1 ]
Han, Lu [1 ]
Hao, Miaomiao [3 ]
Li, Mingyue [3 ]
Yu, Liangzhu [1 ,2 ]
Li, Mincai [1 ,2 ]
机构
[1] Hubei Univ Sci & Technol, Sch Basic Med Sci, Xianning 437100, Peoples R China
[2] Hubei Univ Sci & Technol, Hubei Key Lab Cardiovasc Cerebrovasc & Metab Diso, Xianning 437100, Peoples R China
[3] Hubei Univ Sci & Technol, Sch Pharm, Xianning 437100, Peoples R China
基金
中国国家自然科学基金;
关键词
Klotho; Hypertrophy; Fibrosis; Transforming growth factor-beta 1; Angiotensin II; LEFT-VENTRICULAR HYPERTROPHY; GROWTH-FACTOR-BETA; PROGRESSION; EXPRESSION; RECEPTORS; MODEL;
D O I
10.1016/j.ejphar.2019.172549
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent studies have revealed critical roles of transforming growth factor-beta 1 (TGF-beta 1) and microRNA-132 (miR-132), a downstream mediator of TGF-beta 1, in the pathogenesis of cardiac remodeling. In this study, we tested whether the antiaging protein klotho modifies angiotensin II (Ang II)-induced cardiac remodeling through regulating TGF-beta 1-miR-132 axis. We found that both klotho and the TGF-beta 1 inhibitor LY364947 significantly inhibited cardiac hypertrophy, fibrosis, and dysfunction in Ang II-infused mice, as evidenced by the ratios of heart weight to body weight (HW/BW), heart weight to tibial length (HW/TL), cardiomyocyte cross-sectional area, fibrotic area, and expression of prohypertrophic genes (ANP, beta-MHC) and fibrotic marker genes (alpha-SMA, collagen I), echocardiographic parameters. Meanwhile, klotho also significantly inhibited Ang II-induced protein expression of TGF-beta 1 and phosphorylated Smad2/3 in the heart tissues and cultured cardiomyocytes and cardiac fibroblasts. In vitro experiments demonstrated that Ang II-induced cardiomyocyte hypertrophy and proliferation and activation of cardiac fibroblasts were markedly inhibited by klotho, LY364947 or the miR-132 inhibitor antimiR-beta 2. Both klotho and the TGF-beta 1 inhibitor LY364947 downregulated the miR-132 expression. Additionally, klotho decreased Ang II-induced protein expressions of cardiac fibroblast growth factor (FGF)23 in vivo and in vitro. The decreased protein levels of klotho in serum and renal tissues of Ang II-infused mice were elevated by klotho. Klotho downregulated the protein levels of TGF-beta 1 in renal tissues of Ang II-infused mice. In conclusion, our results suggest that klotho prevents Ang II-induced cardiac remodeling and dysfunction through modifying the TGF-beta 1-miR-132 axis, providing an experimental basis for clinical treatment on cardiac remodeling.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16
    Matsumoto, Emi
    Sasaki, Sayaka
    Kinoshita, Hideyuki
    Kito, Takuya
    Ohta, Hiroya
    Konishi, Morichika
    Kuwahara, Koichiro
    Nakao, Kazuwa
    Itoh, Nobuyuki
    GENES TO CELLS, 2013, 18 (07) : 544 - 553
  • [22] Placental extract suppresses cardiac hypertrophy and fibrosis in an angiotensin II-induced cachexia model in mice
    Yamauchi, Akihiro
    Kamiyoshi, Akiko
    Sakurai, Takayuki
    Miyazaki, Hiroyuki
    Hirano, Eiichi
    Lim, Hong Seok
    Kaku, Taiichi
    Shindo, Takayuki
    HELIYON, 2019, 5 (10)
  • [23] Local angiotensin II and transforming growth factor-β1 in renal fibrosis of rats
    Sun, Y
    Zhang, JK
    Zhang, JQ
    Ramires, FJA
    HYPERTENSION, 2000, 35 (05) : 1078 - 1084
  • [24] Rivaroxaban inhibits angiotensin II-induced cardiac fibrosis via reduction of inflammatory cytokines production through the growth stimulating signal pathway
    Hashikata, T.
    Yamaoka-Tojo, M.
    Ishii, S.
    Kitasato, L.
    Kameda, R.
    Shimohama, T.
    Tojo, T.
    Ako, J.
    EUROPEAN HEART JOURNAL, 2014, 35 : 994 - 995
  • [25] Mice lacking the Cβ subunit of PKA are resistant to angiotensin II-induced cardiac hypertrophy and dysfunction
    Enns L.C.
    Bible K.L.
    Emond M.J.
    Ladiges W.C.
    BMC Research Notes, 3 (1)
  • [26] Pioglitazone Attenuates Angiotensin II-Induced Cardiac Hypertrophy and Fibrosis Through Stimulation of Adiponectin Secretion
    Li, Ping
    Shibata, Rei
    Shimano, Masayuki
    Kato, Mayuko F.
    Ohashi, Taiki
    Cheng, Xianwu
    Wang, Kai
    Nagata, Kohzo
    Ouchi, Noriyuki
    Murohara, Toyoaki
    CIRCULATION, 2008, 118 (18) : S712 - S712
  • [27] Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice
    Li, Yu-qiong
    Li, Xiao-bo
    Guo, Shu-jie
    Chu, Shao-li
    Gao, Ping-jin
    Zhu, Ding-liang
    Niu, Wen-quan
    Jia, Nan
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (03) : 352 - 359
  • [28] Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice
    Yu-qiong Li
    Xiao-bo Li
    Shu-jie Guo
    Shao-li Chu
    Ping-jin Gao
    Ding-liang Zhu
    Wen-quan Niu
    Nan Jia
    Acta Pharmacologica Sinica, 2013, 34 : 352 - 359
  • [29] Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1
    Li, Santie
    Zhu, Zhongxin
    Xue, Mei
    Yi, Xinchu
    Lang, Jiaojiao
    Niu, Chao
    Chen, Gen
    Shen, Yingjie
    Zhang, Hongping
    Zheng, Jiayong
    Zhao, Congcong
    Liang, Yangzhi
    Cong, Weitao
    Wang, Yang
    Jin, Litai
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (06): : 1241 - 1252
  • [30] Androgenic control of transforming growth factor-β signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-β receptor II
    Song, Kyung
    Wang, Hui
    Krebs, Tracy L.
    Kim, Seong-Jin
    Danielpour, David
    CANCER RESEARCH, 2008, 68 (19) : 8173 - 8182